CLL Advocates Network Statement
Much of the information about COVID-19 does not address the concerns of people with chronic lymphocytic leukaemia (CLL). With this statement, we wish to fill this gap and provide extra advice for CLL patients.
CLL patients – whether treated or not, young or old – are immune depressed. Treatment can add to the immune deficiency. In view of the foregoing, CLL patients are therefore at high risk of getting COVID-19 and having more severe symptoms than the general population. Therefore, CLL patients should remain especially vigilant.
The latest version (V6 dd. 6 January 2021) includes a new section on COVID-19 vaccination! It is currently available in English, French, Spanish, German, Greek, Danish, and Kiswahili! Further languages will follow in due course!
Last updated 13 January 2021 – V6 – includes new section on COVID-19 vaccination!
If you can help translate the statement into your respective language so that as many people as possible can benefit from the information therein, we would be grateful for support. Please contact us at email@example.com to ask for the editable files.